<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 1, 2000
AETHLON MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Nevada 33-44567-NY 13-3632859
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No,)
7825 Fay Avenue, Suite 200, La Jolla, California 92037
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including are code (858) 456-5777
--------------
Not applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 2. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT
1. On November 1, 2000, the Company was notified that Freed Maxick Sachs
& Murphy, PC had merged with McGladrey & Pullen, LLP and that Freed
Maxick Sachs & Murphy, PC would no longer be the auditor for the
Registrant. McGladrey & Pullen, LLP was appointed as the Registrant's
new auditor.
2. The auditor's reports from Freed Maxick Sachs & Murphy, PC for the
Registrant's past two fiscal years did not contain an adverse opinion
or a disclaimer of opinion, and were not qualified or modified as to
audit scope, or accounting principles. However, the opinion was
modified due to the risk of uncertainty relating to the Company's
ability to continue as a going concern.
3. The decision to change accountants resulted from the merger and was
not recommended or approved by the board of directors or the audit
committee of the board of directors.
4. During the Registrant's two most recent fiscal years and the
subsequent interim period preceding the change, there have been no
disagreements with Freed Maxick Sachs & Murphy, PC on any matter of
accounting principles or practices, financial statement disclosure, or
auditing scope or procedure.
5. The Registrant has requested Freed Maxick Sachs & Murphy, PC to
furnish a letter addressed to the Commission stating whether it agrees
with the statements made in this Item. Such letter is included in an
exhibit to this Form 8-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Aethlon Medical, Inc.
/s/ FRANKLYN S. BARRY
---------------------------------
Franklyn S. Barry, Jr., President
Date: November 6, 2000
<PAGE>
EXHIBIT INDEX
EXHIBIT 1
Letter from Freed Maxick Sachs & Murphy, PC to the Securities and Exchange
Commission relating to statements included under Item 4 of the Aethlon
Medical, Inc. Form 8-K.
